Literature DB >> 20149171

Radiotherapy for canine chronic superficial keratitis using soft X-rays (15 kV).

Ingrid Allgoewer1, Stefan Hoecht.   

Abstract

OBJECTIVE: To evaluate the effect of soft X-ray therapy in the treatment of refractory chronic superficial keratitis (CSK). ANIMALS STUDIED: Thirteen dogs with severe CSK, that had been refractory to prior medical and/or surgical therapy were treated with soft X-ray therapy. PROCEDURES: Both corneas of each dog were irradiated with soft X-rays (15 kV), to a total dose of 30 Gy, administered as two fractions over 48-96 h. Treatment was carried out under deep sedation in all dogs. Three dogs were treated by superficial lamellar keratectomy 48 h prior to radiotherapy. Changes in the extent of corneal pigmentation, pigment density and corneal vascularization were documented using a semi-quantitative grading scheme, schematic drawings and clinical photographs.
RESULTS: Only minor, transient adverse effects of treatment, such as photophobia, epiphora and blepharitis were noted. Overall the effect of soft X-rays on the course of the keratitis was superior when compared to the effect of Sr-90 irradiation that had been determined in a previous study.
CONCLUSION: Soft X-ray irradiation combined with keratectomy is a safe and effective new treatment option for severe and advanced CSK with significant visual impairment due to corneal pathology.

Entities:  

Mesh:

Year:  2010        PMID: 20149171     DOI: 10.1111/j.1463-5224.2009.00750.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  3 in total

1.  Selecting Quality Service Dogs: Part 1: Morphological and Health Considerations.

Authors:  Lindsay Parenti; Matthew Wilson; Anne M Foreman; Oliver Wirth; B Jean Meade
Journal:  APDT Chron Dog       Date:  2015

2.  Comparative evaluation of decellularized bovine omentum alone and in combination with mitomycin-C in the management of corneal injuries in dogs.

Authors:  A S Thajunnisa; Anoop Sainulabdeen; K M Dileepkumar; Laiju M Philip; V N Vasudevan; C B Devanand
Journal:  Vet World       Date:  2020-11-11

3.  Topical bevacizumab for the treatment of corneal vascularization in dogs: A case series.

Authors:  Lisa-Marie Muellerleile; Michael Bernkopf; Michael Wambacher; Barbara Nell
Journal:  Vet Ophthalmol       Date:  2021-09-06       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.